BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 16403256)

  • 21. Increased expression of multidrug resistance gene (MDR1) at relapse in a child with acute lymphoblastic leukemia.
    Kourti M; Vavatsi N; Gombakis N; Tzimagiorgis G; Sidi V; Koliouskas D; Athanassiadou F
    Pediatr Hematol Oncol; 2006 Sep; 23(6):489-94. PubMed ID: 16849280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways.
    Scupoli MT; Donadelli M; Cioffi F; Rossi M; Perbellini O; Malpeli G; Corbioli S; Vinante F; Krampera M; Palmieri M; Scarpa A; Ariola C; Foà R; Pizzolo G
    Haematologica; 2008 Apr; 93(4):524-32. PubMed ID: 18322253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coexpression of p53 protein and MDR functional phenotype in leukemias: the predominant association in chronic myeloid leukemia.
    Cavalcanti GB; Vasconcelos FC; Pinto de Faria G; Scheiner MA; de Almeida Dobbin J; Klumb CE; Maia RC
    Cytometry B Clin Cytom; 2004 Sep; 61(1):1-8. PubMed ID: 15351976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup.
    Borssén M; Cullman I; Norén-Nyström U; Sundström C; Porwit A; Forestier E; Roos G
    Exp Hematol; 2011 Dec; 39(12):1144-51. PubMed ID: 21914494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expression of bcl-2, c-myc genes and their relationship in patients with acute leukemia].
    Chen SP; Tang GC
    Hunan Yi Ke Da Xue Xue Bao; 2001 Feb; 26(1):83-5. PubMed ID: 12536628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant expression of tumor suppressor genes and their association with chimeric oncogenes in pediatric acute lymphoblastic leukemia.
    Kustanovich AM; Savitskaja TV; Bydanov OI; Belevtsev MV; Potapnev MP
    Leuk Res; 2005 Nov; 29(11):1271-6. PubMed ID: 15878620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel germline p53 splicing mutation in a pediatric patient with a second malignant neoplasm.
    Felix CA; Strauss EA; D'Amico D; Tsokos M; Winter S; Mitsudomi T; Nau MM; Brown DL; Leahey AM; Horowitz ME
    Oncogene; 1993 May; 8(5):1203-10. PubMed ID: 8479743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of Smad3 in acute T-cell lymphoblastic leukemia.
    Wolfraim LA; Fernandez TM; Mamura M; Fuller WL; Kumar R; Cole DE; Byfield S; Felici A; Flanders KC; Walz TM; Roberts AB; Aplan PD; Balis FM; Letterio JJ
    N Engl J Med; 2004 Aug; 351(6):552-9. PubMed ID: 15295048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutational analysis of p53 in 16 cases of acute lymphoblastic leukemia and Burkitt's lymphoma.
    Nomdedéu JF; Lete I; Baiget M; Lasa A; Estivill C; Rubiol E; Badell I; Pardo N; Cubells J; Mateu R; Brunet S; Bordes R; Soler J
    Haematologica; 1997; 82(5):550-4. PubMed ID: 9407719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Translational regulation of human p53 gene expression.
    Fu L; Minden MD; Benchimol S
    EMBO J; 1996 Aug; 15(16):4392-401. PubMed ID: 8861966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoexpression of p53 and hMSH2 in oral squamous cell carcinoma and oral dysplastic lesions in Yemen: relationship to oral risk habits and prognostic factors.
    Helal Tel A; Fadel MT; El-Thobbani AK; El-Sarhi AM
    Oral Oncol; 2012 Feb; 48(2):120-4. PubMed ID: 21937259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expressions of cyclin E2 and survivin in acute leukemia and their correlation.
    Wang Y; Xu SR; Lin FR; Guo XN; Ren JH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):337-42. PubMed ID: 16638210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High expression of CEACAM6 and CEACAM8 mRNA in acute lymphoblastic leukemias.
    Lasa A; Serrano E; Carricondo M; Carnicer MJ; Brunet S; Badell I; Sierra J; Aventín A; Nomdedéu JF
    Ann Hematol; 2008 Mar; 87(3):205-11. PubMed ID: 17909799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of cyclin D1 in de novo and relapsed childhood acute lymphoblastic leukemia.
    Sauerbrey A; Häfer R; Zintl F; Volm M
    Anticancer Res; 1999; 19(1B):645-9. PubMed ID: 10216470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute lymphoblastic leukemia with low hypodiploid/near triploid karyotype is a specific clinical entity and exhibits a very high TP53 mutation frequency of 93%.
    Mühlbacher V; Zenger M; Schnittger S; Weissmann S; Kunze F; Kohlmann A; Bellos F; Kern W; Haferlach T; Haferlach C
    Genes Chromosomes Cancer; 2014 Jun; 53(6):524-36. PubMed ID: 24619868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mismatch repair protein hMSH2 in primary drug resistance in in vitro human malignant gliomas.
    Rellecke P; Kuchelmeister K; Schachenmayr W; Schlegel J
    J Neurosurg; 2004 Oct; 101(4):653-8. PubMed ID: 15481721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylation of CpG dinucleotides and/or CCWGG motifs at the promoter of TP53 correlates with decreased gene expression in a subset of acute lymphoblastic leukemia patients.
    Agirre X; Vizmanos JL; Calasanz MJ; García-Delgado M; Larráyoz MJ; Novo FJ
    Oncogene; 2003 Feb; 22(7):1070-2. PubMed ID: 12592393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p16: at last a tumor suppressor gene involved in childhood acute lymphoblastic leukemias!
    Leblanc T
    Pediatr Hematol Oncol; 1997; 14(2):iii-viii. PubMed ID: 9089734
    [No Abstract]   [Full Text] [Related]  

  • 39. [Expression of Gli1 in Adult Acute Lymphoblastic Leukemia and Its Clinical Significance].
    Long B; Zhang XZ; Li XD; Long ZJ; Wang XZ; Liu JJ; Lin DJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Aug; 23(4):946-9. PubMed ID: 26314423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutations of TP53 gene in adult acute lymphoblastic leukemia at diagnosis do not affect the achievement of hematologic response but correlate with early relapse and very poor survival.
    Salmoiraghi S; Montalvo ML; Ubiali G; Tosi M; Peruta B; Zanghi P; Oldani E; Boschini C; Kohlmann A; Bungaro S; Intermesoli T; Terruzzi E; Angelucci E; Cavattoni I; Ciceri F; Bassan R; Rambaldi A; Spinelli O
    Haematologica; 2016 Jun; 101(6):e245-8. PubMed ID: 26992948
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.